Evidence map›Paper›PMID 32761484›Full record

ArticlePediatric nephrology (Berlin, Germany)2021

Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus.

Oren Pleniceanu, Gilad Twig, Dorit Tzur, Noah Gruber, Michal Stern-Zimmer, Arnon Afek, Tomer Erlich, Lital Keinan-Boker, Karl Skorecki, Ronit Calderon-Margalit and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Complications and Treatment of Early-Onset Type 2 Diabetes.International journal of endocrinology and metabolism · 2023
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Oren PleniceanuDepartment of Military Medicine, Hebrew University of Jerusalem, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.ORCID http://orcid.org/0000-0003-0537-4469
Gilad TwigDepartment of Military Medicine, Hebrew University of Jerusalem, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Dorit TzurDepartment of Military Medicine, Hebrew University of Jerusalem, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Noah GruberSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Michal Stern-ZimmerSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Arnon AfekSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Tomer ErlichDepartment of Military Medicine, Hebrew University of Jerusalem, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Lital Keinan-BokerIsrael Center for Disease Control, Ministry of Health, Ramat Gan, Israel.
Karl SkoreckiAzrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel.
Ronit Calderon-Margalit *Hadassah-Hebrew University Braun School of Public Health, Jerusalem, Israel. ronitcm@gmail.com.
Asaf Vivante *Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. asafvivante@gmail.com.
Tel Aviv University · ILHebrew University of Jerusalem · ILBar-Ilan University · ILIsrael Ministry of Health · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic kidney disease (DKD) is becoming increasingly common among children. We aimed to estimate the risk of end-stage renal disease (ESKD) and mortality among adolescents with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) and normal renal function compared with non-diabetics. We hypothesized that childhood onset T1DM vs. T2DM would be associated with a different risk profile for developing ESKD and its complications.

methodsA nationwide, population-based, retrospective cohort study, including 1,500,522 adolescents examined for military service between 1967 and 1997, which were classified according to the presence and type of diabetes. Data were linked to the Israeli ESKD registry. Cox proportional-hazards models were used to estimate the hazard ratio (HR) for ESKD.

resultsAt study enrolment, 1183 adolescents had T1DM and 196 had T2DM. ESKD developed in 2386 non-diabetic individuals (0.2%) compared with 72 individuals (6.1%) with T1DM and 8 individuals (4.1%) with T2DM. Participants with T1DM were younger at ESKD onset than participants with T2DM (median age, 36.0 vs. 40.5 years, P < 0.05). In a multivariate model adjusted for age, sex, paternal origin, enrollment year, BMI, and blood pressure, T1DM and T2DM were associated with HR of 36.4 (95% CI 28.3-46.9) and 19.3 (95% CI 9.6-38.8) for ESKD, respectively. Stratification according to sex, ethnicity, immigration, and socioeconomic status did not materially change the HR. During the follow-up period, mortality rates were higher in T2DM as compared with T1DM and controls (8.7 %, 2.2%, and 2.7% respectively).

conclusionsT1DM and T2DM in adolescents with normal renal function confer a significantly increased risk for ESKD. T1DM is associated with younger age at ESKD onset while T2DM is associated with higher mortality rate.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NephropathiesKidney Failure, ChronicAdolescentAdultChildHumansRetrospective StudiesRisk FactorsChronic kidney disease (CKD)End-stage kidney disease (ESKD)Type 1 diabetes mellitusType 2 diabetes mellitus

Identifiers

PMID32761484
OpenAlexW3046970115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.